Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A network dysfunction perspective on neurodegenerative diseases.

Jorge J Palop1, Jeannie Chin, Lennart Mucke

  • 1Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco, California 94158, USA.

Nature
|October 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglia-Specific Molecular Magnetic Resonance Imaging Probe Enables Noninvasive Separation of Parkinsonian Mice from Controls.

bioRxiv : the preprint server for biology·2026
Same author

Early-Stage Corticostriatal Hyperactivity Impairs Cognitive Flexibility Alongside Striatal Cholinergic Dysfunction in an Alzheimer's Disease Model.

Nature communications·2026
Same author

Therapeutic targeting of fibrin-microglia interactions ameliorates Alzheimer's disease-related hyperexcitability and brain network dysfunction.

bioRxiv : the preprint server for biology·2026
Same author

Resilience to neuronal hyperactivity and restoration of the neuroimmune interactome by blocking fibrin-induced microglia activation in Alzheimers disease.

bioRxiv : the preprint server for biology·2026
Same author

To Seize or Not to Seize? That is the (Epigenetic) Question.

Epilepsy currents·2026
Same author

Parvalbumin Neuron-Targeted Loss of Alzheimer's Disease Risk Gene <i>BIN1</i> Is Insufficient to Drive Cognitive or Network Excitability Changes.

eNeuro·2026
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
See all related articles

Neurological symptoms in Alzheimer's disease patients fluctuate daily, not due to cell loss, but likely due to neural network variations or temporary protein intoxication. This suggests new therapeutic avenues for neurodegenerative disorders.

Area of Science:

  • Neuroscience
  • Neurology
  • Pathology

Background:

  • Patients with Alzheimer's disease (AD) and other neurodegenerative disorders exhibit significant daily variations in neurological functions.
  • These fluctuations are not attributable to neuronal death or regeneration.

Purpose of the Study:

  • To propose a novel explanation for the daily fluctuations observed in neurodegenerative diseases.
  • To explore the potential role of neural network activity and protein intoxication in these variations.

Main Methods:

  • This study is primarily theoretical, based on existing clinical observations and pathological understanding of neurodegenerative diseases.
  • It synthesizes current knowledge on neural network dynamics and protein aggregation in the brain.

Related Experiment Videos

Main Results:

  • Daily fluctuations in neurological function are unlikely to stem from changes in neuron count.
  • These variations may correlate with dynamic changes in neural network activity.
  • Temporary clearance or management of toxic protein aggregates by the brain could explain intermittent symptom improvement.

Conclusions:

  • The observed functional fluctuations in neurodegenerative conditions suggest a dynamic interplay of neural network function and protein toxicity.
  • Understanding these mechanisms offers potential for developing novel therapeutic strategies targeting neural network modulation or protein clearance.